Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes

Abstract

The use of such lymphocytes for adoptive cell transfer purposes, associated with other approaches modulating the tumor microenvironment, would be a promising alternative to improve immunotherapy efficacy in solid tumors.